KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) EBT (2016 - 2025)

Zimmer Biomet Holdings has reported EBT over the past 17 years, most recently at $98.0 million for Q4 2025.

  • Quarterly results put EBT at $98.0 million for Q4 2025, down 66.09% from a year ago — trailing twelve months through Dec 2025 was $830.8 million (down 19.85% YoY), and the annual figure for FY2025 was $830.8 million, down 19.85%.
  • EBT for Q4 2025 was $98.0 million at Zimmer Biomet Holdings, down from $279.2 million in the prior quarter.
  • Over the last five years, EBT for ZBH hit a ceiling of $302.2 million in Q2 2024 and a floor of -$74.8 million in Q4 2022.
  • Median EBT over the past 5 years was $217.2 million (2023), compared with a mean of $197.8 million.
  • Biggest five-year swings in EBT: plummeted 314.33% in 2022 and later skyrocketed 480.35% in 2023.
  • Zimmer Biomet Holdings' EBT stood at $34.9 million in 2021, then plummeted by 314.33% to -$74.8 million in 2022, then skyrocketed by 480.35% to $284.5 million in 2023, then grew by 1.58% to $289.0 million in 2024, then crashed by 66.09% to $98.0 million in 2025.
  • The last three reported values for EBT were $98.0 million (Q4 2025), $279.2 million (Q3 2025), and $224.6 million (Q2 2025) per Business Quant data.